Current and future uses of recombinant interferon alpha in the treatment of low-grade non-Hodgkin's lymphoma
- 1 February 1987
- Vol. 59 (S3) , 658-663
- https://doi.org/10.1002/1097-0142(19870201)59:3+<658::aid-cncr2820591315>3.0.co;2-q
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Phase I study of recombinant leukocyte A human interferon combined with BCNU in selected patients with advanced cancer.Journal of Clinical Oncology, 1986
- Clinical trial of recombinant leukocyte A interferon as initial therapy for favorable histology non-Hodgkin's lymphomas and chronic lymphocytic leukemia. An Eastern Cooperative Oncology Group pilot study.Journal of Clinical Oncology, 1986
- Treatment of multiple myeloma with recombinant alpha-interferonBlood, 1986
- Human interferon alpha in malignant lymphoma and Hodgkin's disease. Results of the american cancer society trialCancer, 1985
- Karnofsky memorial lecture. The low-grade non-Hodgkin's lymphomas: challenges and opportunities.Journal of Clinical Oncology, 1985
- Treatment of Advanced Non-Hodgkin's Lymphoma with Recombinant Leukocyte a InterferonNew England Journal of Medicine, 1984
- Collaborative phase I-II study of recombinant DNA-produced leukocyte interferon (clone A) in metastatic breast cancer, malignant lymphoma, and multiple myelomaThe American Journal of Medicine, 1984
- Follow-up observations on the effect of human leukocyte interferon in non-Hodgkin's lymphomaBlood, 1981
- Non-hodgkin's lymphomas iv. clinicopathologic correlation in 405 casesCancer, 1973
- Follicular lymphoma.A re-evaluation of its position in the scheme of malignant lymphoma based on a survey of 253 casesCancer, 1956